SCHEMBL24800994

SCHEMBL24800994

CN(C)c1ccc2cc(-c3coc4ccccc34)c(N)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 1/20 0.43
▸ APP P05067 1/20 0.43
▸ MAOB P27338 2/20 0.38
▸ MAOA P21397 1/20 0.38
▸ GRK2 P25098 1/20 0.36
▸ PSMB5 P28074 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ KLF5 Q13887 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ APAF1 O14727 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ IKBKE Q14164 2/20 0.33
▸ TBK1 Q9UHD2 2/20 0.33
▸ PDGFRB P09619 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24800992 0.75 APP (0.43) TERTAPPPSMB5NPC1RAB9A
SCHEMBL18227093 0.75 TERT (0.49) TERTAPPPSMB5NPC1RAB9A
SCHEMBL16739391 0.75 TERT (0.49) TERTAPPPSMB5NPC1RAB9A
SCHEMBL18227070 0.75 TERT (0.49) TERTAPPPSMB5NPC1RAB9A
SCHEMBL24800997 0.74 CDK5 (0.43) TERTAPPNPC1RAB9ACCNT1
SCHEMBL31089909 0.74 CDK5 (0.43) TERTAPPNPC1RAB9ACCNT1
SCHEMBL18227073 0.71 TERT (0.47) TERTAPPPSMB5NPC1RAB9A
SCHEMBL18227144 0.69 TERT (0.49) TERTAPPPSMB5NPC1RAB9A
SCHEMBL22969407 0.69 GRK2 (0.40) MAOBMAOAGRK2MEN1KMT2A
SCHEMBL29495787 0.69 GRK2 (0.40) MAOBMAOAGRK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022271676-A1 INDOLE-SUBSTITUTED QUINOLINES AND THEIR COMBINATION WITH PLK1 INHIBITORS FOR THE TREATMENT OF CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2022-12-29 — — WO disclosed
Send feedback